No,구분,개별,평가의뢰일,평가의뢰기관,재평가,평가의뢰종목,법인번호,평가종류,회차,민감도,주기,기준일,평가값송부일,보고서송부일,민감도송부일,평가담당자,공수,전기평가,RM,결과보고서송부,등록월,등록그룹,담당자,연락처,Mail,평가목적,종목등록일
184,-,개별종목,2024-10-07,제이케이엘파트너스,재평가,지에스아이티엠,1101113451731 ,A07,0,-,년,2024-09-30,2024-11-05,2024-11-11,-,김예림, 1.0 ,오수현,신원준,신원준,202411,[Y]금융기관,신보영이사,"02-2016-5927,010-5033-2241",byshin@jklpartners.co.kr,국민연금/교직원공제회제출,2
185,-,개별종목,2024-10-07,제이케이엘파트너스,재평가,지에스아이티엠,1101113451731 ,A01,0,-,년,2024-09-30,2024-11-05,2024-11-11,-,김예림, - ,오수현,신원준,신원준,202411,[Y]금융기관,신보영이사,"02-2016-5927,010-5033-2241",byshin@jklpartners.co.kr,국민연금/교직원공제회제출,2
207,-,개별종목,2024-10-08,티에스인베스트먼트,재평가,프렌트립,1101115279199 ,A01,0,-,연말,2024-09-30,2024-11-08,2024-11-14,-,이상민, 1.0 ,오수현,유재호,유재호,202411,[Y]금융기관,관리본부임혁빈부장,"02-6250-5705,010-2247-5835",imhb@tsinvestment.co.kr; jwlee@tsinvestment.co.kr; yj.kim@tsinvestment.co.kr,교직원공제회/고용보험기금제출,2
208,-,개별종목,2024-10-08,티에스인베스트먼트,재평가,프렌트립,1101115279199 ,A07,0,-,연말,2024-09-30,2024-11-08,2024-11-14,-,이상민, - ,오수현,유재호,유재호,202411,[Y]금융기관,관리본부임혁빈부장,"02-6250-5705,010-2247-5835",imhb@tsinvestment.co.kr; jwlee@tsinvestment.co.kr; yj.kim@tsinvestment.co.kr,교직원공제회/고용보험기금제출,2
288,별첨보고서,개별종목,2024-10-08,아이엠엠인베스트먼트,재평가,헬리녹스,1101115221794 ,A01,0,-,반기,2024-09-30,평가철회,평가철회,-,이진주, 1.0 ,오수현,강성은,강성은,평가철회,평가철회,박상현매니저,02-2112-1729,shpark@imminvestment.com,국민연금제출,2
289,-,개별종목,2024-10-08,아이엠엠인베스트먼트,재평가,헬리녹스,1101115221794 ,A05,0,-,반기,2024-09-30,2024-11-06,2024-11-11,-,이진주, - ,오수현,강성은,강성은,202411,[Y]금융기관,박상현매니저,02-2112-1729,shpark@imminvestment.com,국민연금제출,2
290,-,개별종목,2024-10-08,아이엠엠인베스트먼트,재평가,헬리녹스,1101115221794 ,A05,1,-,반기,2024-09-30,2024-11-06,2024-11-11,-,이진주, - ,오수현,강성은,강성은,202411,[Y]금융기관,박상현매니저,02-2112-1729,shpark@imminvestment.com,국민연금제출,2
353,2차 평가값 송부일 : 2024-11-15,개별종목,2024-10-10,아주아이비투자,재평가,"Carbon Biosciences, Inc.",KBP2022030098,A05,0,-,년,2024-09-30,2024-11-12,2024-11-18,-,백형진, 1.0 ,오수현,강성은,강성은,202411,[Y]금융기관,유수지매니저,02-3451-9251,sjyou@ajuib.co.kr,재무보고목적,2
354,2차 평가값 송부일 : 2024-11-15,개별종목,2024-10-10,아주아이비투자,재평가,"Carbon Biosciences, Inc.",KBP2022030098,D02,0,-,년,2024-09-30,평가철회,평가철회,-,백형진, - ,오수현,강성은,강성은,평가철회,평가철회,유수지매니저,02-3451-9251,sjyou@ajuib.co.kr,재무보고목적,2
369,2차 평가값 송부일 : 2024-11-15,개별종목,2024-10-10,아주아이비투자,신규,하나옵트로닉스,1648110117700 ,A07,0,-,년,2024-09-30,2024-11-12,2024-11-18,-,강승현, 1.0 ,오수현,강성은,강성은,202411,[Y]금융기관,유수지매니저,02-3451-9251,sjyou@ajuib.co.kr,재무보고목적,2
421,-,기초자산,고려아연펀드(기초자산),디에스씨테크밸류업펀드2호,재평가,"GENOME INSIGHT, Inc.",KBP2023120126,A05,0,-,년,2024-09-30,2024-11-15,보고서제공X,-,원정우, - ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
425,-,기초자산,고려아연펀드(기초자산),디에스씨테크밸류업펀드2호,재평가,하플사이언스,1311110537282 ,A07,0,-,년,2024-09-30,2024-11-15,보고서제공X,-,김에스더, 0.6 ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
436,-,기초자산,고려아연펀드(기초자산),디에스씨테크밸류업펀드2호,재평가,엘베이스,1101115886366 ,A07,0,-,년,2024-09-30,2024-11-15,보고서제공X,-,유재호, - ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
439,-,기초자산,고려아연펀드(기초자산),디에스씨테크밸류업펀드2호,재평가,큐라미스,1101116789931 ,A05,1,-,년,2024-09-30,2024-11-15,보고서제공X,-,서경덕, - ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
442,-,기초자산,고려아연펀드(기초자산),티비티오픈이노베이션투자조합,재평가,모노랩스,1101116759174 ,A07,0,-,년,2024-09-30,2024-11-15,보고서제공X,-,서동현, - ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
443,-,기초자산,고려아연펀드(기초자산),티비티오픈이노베이션투자조합,재평가,모노랩스,1101116759174 ,A07,1,-,년,2024-09-30,2024-11-15,보고서제공X,-,서동현, - ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
450,-,기초자산,고려아연펀드(기초자산),티비티오픈이노베이션투자조합,재평가,콜라보그라운드,1101116440880 ,A07,0,-,년,2024-09-30,2024-11-15,보고서제공X,-,이현승, - ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
496,-,기초자산,고려아연펀드(기초자산),미래에셋글로벌유니콘사모투자,재평가,The ON Platform Inc.,KBP2023120135,A05,0,-,년,2024-09-30,2024-11-15,보고서제공X,-,채동우, - ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
552,-,기초자산,고려아연펀드(기초자산),타임폴리오바이오육성투자조합,재평가,매직불릿테라퓨틱스,1101118283957 ,A07,0,-,년,2024-09-30,2024-11-15,보고서제공X,-,유재호, - ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
669,-,개별종목,2024-10-15,나우아이비캐피탈,재평가,대한조선,2047110003887 ,D02,2,-,반기 ,2024-09-30,2024-11-11,2024-11-15,-,변혜진, 1.0 ,오수현,유재호,유재호,202411,[Y]금융기관,김혜진대리,02-565-0739,hjkim@nauib.com,국민연금제출,2
673,-,개별종목,2024-10-15,나우아이비캐피탈,재평가,대한조선,2047110003887 ,D02,3,-,반기 ,2024-09-30,2024-11-11,2024-11-15,-,변혜진, - ,오수현,유재호,유재호,202411,[Y]금융기관,김혜진대리,02-565-0739,hjkim@nauib.com,국민연금제출,2
716,-,개별종목,2024-10-16,KB인베스트먼트,신규,피알앤디컴퍼니,1101115599050 ,A07,3,-,미정,2024-09-30,2024-11-14,2024-11-18,-,변혜진, 1.0 ,오수현,최수민,최수민,202411,[Y]금융기관,이새록수석팀장,02-3015-4786,saerock.lee@kbfg.com,국민연금제출,2
717,-,개별종목,2024-10-16,KB인베스트먼트,신규,피알앤디컴퍼니,1101115599050 ,A07,4,-,미정,2024-09-30,2024-11-14,2024-11-18,-,변혜진, - ,오수현,최수민,최수민,202411,[Y]금융기관,이새록수석팀장,02-3015-4786,saerock.lee@kbfg.com,국민연금제출,2
745,-,개별종목,2024-10-17,스톤브릿지벤처스,재평가,마이셀,2001110591838 ,A07,0,-,년,2024-09-30,2024-11-14,2024-11-18,-,원정우, 1.0 ,오수현,강승현,강승현,202411,[Y]금융기관,0,0,0,국민연금제출,2
760,-,개별종목,2024-10-17,스톤브릿지벤처스,재평가,아이디어허브,1101116239407 ,A07,0,-,년,2024-09-30,2024-11-14,2024-11-18,-,원정우, 1.0 ,오수현,강승현,강승현,202411,[Y]금융기관,0,0,0,국민연금제출,2
761,-,개별종목,2024-10-17,스톤브릿지벤처스,재평가,아이디어허브,1101116239407 ,A07,1,-,년,2024-09-30,2024-11-14,2024-11-18,-,원정우, - ,오수현,강승현,강승현,202411,[Y]금융기관,0,0,0,국민연금제출,2
762,-,개별종목,2024-10-17,스톤브릿지벤처스,재평가,아이디어허브,1101116239407 ,A07,2,-,년,2024-09-30,2024-11-14,2024-11-18,-,원정우, - ,오수현,강승현,강승현,202411,[Y]금융기관,0,0,0,국민연금제출,2
816,-,기초자산,고려아연펀드(기초자산),파트너스글로벌헬스케어클로버펀드,신규,"Sail Biomedicines, Inc.(구,Senda Biosciences)",KBP2022030107,A05,77,-,년,2024-09-30,2024-11-15,보고서제공X,-,정은채, 0.6 ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
957,-,기초자산,무림캐피탈펀드(기초자산),신한프랙시스케이그로쓰글로벌사모투자전문회사,재평가,"티앤더블유코리아(구,토다이코리아)",1101113843673 ,A01,0,-,반기 ,2024-11-30,2024-12-06,보고서제공X,-,원정우, 0.4 ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
991,-,기초자산,무림캐피탈펀드(기초자산),아르게스에이원창업벤처전문사모투자,재평가,유니젯,1311110083235 ,A05,0,-,반기 ,2024-11-30,2024-12-06,보고서제공X,-,백형진, 0.4 ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
994,-,기초자산,무림캐피탈펀드(기초자산),마일스톤마젠타사모투자,재평가,케이크,1101117644986 ,A07,0,-,반기 ,2024-11-30,2024-12-06,보고서제공X,-,이문수, 0.4 ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
995,-,기초자산,무림캐피탈펀드(기초자산),마일스톤마젠타사모투자,재평가,케이크,1101117644986 ,A07,1,-,반기 ,2024-11-30,2024-12-06,보고서제공X,-,이문수, - ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
1070,최종보고서 : 2025-01-15,개별종목,2024-10-31,"롯데홈쇼핑(구,우리홈쇼핑)",신규,롯데홈쇼핑이노베이션펀드1호,KBP2024110007,B01,0,-,반기 ,2024-09-30,2024-11-22,2024-12-09,-,김에스더, 1.0 ,신규,원정우,원정우,202411,[A]롯데,"송승혁매니저, 이재영","02-2168-5176, 02-2168-5150",ssh810@lotte.net;j.y.lee@lotte.net,회계반영,2
1089,-,개별종목,2024-10-31,미래에셋벤처투자,신규,크리모,1717110129302 ,A07,0,-,미정,2024-09-30,2024-11-13,2024-11-20,-,최수민, 1.0 ,신규,오영석,오영석,202411,[Y]금융기관,김주희매니저,02-6205-2640,juhee@miraeasset.com,국민연금제출,2
1140,-,개별종목,2024-11-01,미래나노텍,재평가,에이피트바이오,1101116955003 ,A07,0,-,연말,2024-11-30,2024-12-24,2024-12-31,-,이진주, 1.0 ,오수현,신원준,신원준,202411,[X]일반기업,경초현프로 ,"043-710-1550, 010-8842-5265 ",chkyung@mntech.co.kr ,회계반영,2
1141,-,개별종목,2024-11-01,미래나노텍,재평가,에이피트바이오,1101116955003 ,A04,77,-,연말,2024-11-30,2024-12-24,2024-12-31,-,이진주, - ,오수현,신원준,신원준,202411,[X]일반기업,경초현프로 ,"043-710-1550, 010-8842-5265 ",chkyung@mntech.co.kr ,회계반영,2
1161,-,기초자산,네오위즈홀딩스펀드(기초자산),IMM세컨더리벤처펀드5호,재평가,아이디어허브,1101116239407 ,A07,0,-,분기 ,2024-09-30,평가철회,평가철회,-,원정우, - ,오수현,-,-,평가철회,평가철회,0,0,0,-,2
1168,-,기초자산,네오위즈홀딩스펀드(기초자산),IMM세컨더리벤처펀드5호,재평가,아이디어허브,1101116239407 ,A07,1,-,분기 ,2024-09-30,평가철회,평가철회,-,원정우, - ,오수현,-,-,평가철회,평가철회,0,0,0,-,2
1169,-,기초자산,네오위즈홀딩스펀드(기초자산),IMM세컨더리벤처펀드5호,재평가,아이디어허브,1101116239407 ,A07,2,-,분기 ,2024-09-30,2024-11-29,보고서제공X,-,원정우, - ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
1510,-,기초자산,사립학교교직원연금공단펀드(기초자산),에이티넘성장투자조합2023,재평가,피알앤디컴퍼니,1101115599050 ,A07,3,-,분기,2024-09-30,2024-12-17,보고서제공X,-,변혜진, - ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
1570,-,기초자산,사립학교교직원연금공단펀드(기초자산),아주좋은벤처펀드2.0,재평가,"Carbon Biosciences, Inc.",KBP2022030098,A05,5,-,분기 ,2024-09-30,2024-12-17,보고서제공X,-,백형진, - ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
1571,-,기초자산,사립학교교직원연금공단펀드(기초자산),아주좋은벤처펀드2.0,재평가,"Carbon Biosciences, Inc.",KBP2022030098,D02,5,-,분기 ,2024-09-30,2024-12-17,보고서제공X,-,백형진, - ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
1572,-,기초자산,사립학교교직원연금공단펀드(기초자산),아주좋은벤처펀드2.0,재평가,"Carbon Biosciences, Inc.",KBP2022030098,D02,6,-,분기 ,2024-09-30,2024-12-17,보고서제공X,-,백형진, - ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
1637,-,기초자산,사립학교교직원연금공단펀드(기초자산),아주좋은벤처펀드2.0,재평가,하나옵트로닉스,1648110117700 ,A07,5,-,분기 ,2024-09-30,2024-12-17,보고서제공X,-,강승현, - ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
1804,-,기초자산,사립학교교직원연금공단펀드(기초자산),서울투자성장산업벤처조합,재평가,이스트엔드,1101116159150 ,A07,0,-,미정,2024-09-30,2024-12-17,보고서제공X,-,김영하, 0.4 ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
1832,24년평가대상,기초자산,사립학교교직원연금공단펀드(기초자산),에이티넘성장투자조합2020,재평가,XL8 Inc.,KBP2022110028,A05,0,-,연말,2024-09-30,2024-12-17,보고서제공X,-,이상민, - ,윤현빈,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
1833,-,기초자산,사립학교교직원연금공단펀드(기초자산),에이티넘성장투자조합2020,재평가,XL8 Inc.,KBP2022110028,A05,1,-,연말,2024-09-30,2024-12-17,보고서제공X,-,이상민, - ,윤현빈,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
1917,-,기초자산,사립학교교직원연금공단펀드(기초자산),에이티넘성장투자조합2020,재평가,피알앤디컴퍼니,1101115599050 ,A07,2,-,연말,2024-09-30,2024-12-17,보고서제공X,-,변혜진, - ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
1918,-,기초자산,사립학교교직원연금공단펀드(기초자산),에이티넘성장투자조합2020,재평가,피알앤디컴퍼니,1101115599050 ,A07,1,-,연말,2024-09-30,2024-12-17,보고서제공X,-,변혜진, - ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
1923,-,기초자산,사립학교교직원연금공단펀드(기초자산),스카이레이크에쿼티제1호사모투자,재평가,SKYLAKE EQUITY INVESTMENT II S.A.R.L,KBP2022030094,A01,0,-,연말,2024-09-30,2024-12-17,보고서제공X,-,윤광일, 0.4 ,김수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
1956,-,기초자산,사립학교교직원연금공단펀드(기초자산),미래창조LB선도기업투자펀드20호,재평가,"에스엘테라퓨틱스(구,스템랩)",1101114643626 ,A01,0,-,연말,2024-09-30,평가철회,평가철회,-,강승현, - ,오수현,-,-,평가철회,평가철회,0,0,0,-,2
1973,-,기초자산,네오위즈파트너스펀드(기초자산),스톤브릿지티케브릿징사모투자,재평가,아이디어허브,1101116239407 ,A07,0,-,연말,2024-09-30,2024-11-29,보고서제공X,-,원정우, - ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
1974,-,기초자산,네오위즈파트너스펀드(기초자산),스톤브릿지티케브릿징사모투자,재평가,아이디어허브,1101116239407 ,A07,1,-,연말,2024-09-30,2024-11-29,보고서제공X,-,원정우, - ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
2003,SPC,기초자산,네오위즈파트너스펀드(기초자산),제이앤제1호사모투자,재평가,하운드,1101118779344 ,A07,0,-,연말,2024-09-30,2024-11-29,보고서제공X,-,윤광일, - ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
2007,SPC,기초자산,네오위즈파트너스펀드(기초자산),제이앤제1호사모투자,재평가,갤럭시미디어,1101118270970 ,A04,0,-,연말,2024-09-30,2024-11-29,보고서제공X,-,윤광일, - ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
2021,SPC,기초자산,네오위즈파트너스펀드(기초자산),제이앤제1호사모투자,재평가,솔라홀딩스,1101118953914 ,A01,0,-,연말,2024-09-30,2024-11-29,보고서제공X,-,윤광일, - ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
2111,-,기초자산,조이시티펀드(기초자산),라구나청년창업투자조합제1호,재평가,아이디어허브,1101116239407 ,B07,0,-,년,2024-09-30,2024-12-13,보고서제공X,-,원정우, - ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
2112,-,기초자산,조이시티펀드(기초자산),라구나청년창업투자조합제1호,재평가,아이디어허브,1101116239407 ,A07,4,-,년,2024-09-30,2024-12-13,보고서제공X,-,원정우, - ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
2124,-,기초자산,조이시티펀드(기초자산),라구나청년창업투자조합제1호,재평가,넥스트스테이지,1801110981901 ,A01,0,-,년,2024-09-30,2024-12-13,보고서제공X,-,서경덕, 0.4 ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
2148,-,기초자산,조이시티펀드(기초자산),라구나창업초기투자조합제2호,재평가,에이피트바이오,1101116955003 ,A01,0,-,년,2024-09-30,2024-12-13,보고서제공X,-,이진주, - ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
2168,-,기초자산,조이시티펀드(기초자산),케이제이앤1호게임전문투자조합,재평가,"GOODGAME Technology Co.,Limited",KBP2023120098,A01,0,-,년,2024-09-30,2024-12-13,보고서제공X,-,윤광일, - ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
2241,-,기초자산,네오위즈홀딩스펀드(기초자산),데일리임파워링바이오헬스케어펀드3호,신규,"에스엘테라퓨틱스(구,스템랩)",1101114643626 ,A01,0,-,연말,2024-09-30,2024-11-29,보고서제공X,-,강승현, 0.4 ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
2276,-,개별종목,2024-11-08,아주아이비투자,재평가,헬리녹스,1101115221794 ,A01,0,-,반기 ,2024-12-31,2024-12-17,2024-12-17,-,이진주, 1.0 ,오수현,강성은,강성은,202412,[Y]금융기관,구자은매니저,02-3451-9245,kje@ajuib.co.kr,회계반영,2
2277,-,개별종목,2024-11-08,아주아이비투자,재평가,헬리녹스,1101115221794 ,A05,0,-,반기 ,2024-12-31,2024-12-17,2024-12-17,-,이진주, - ,오수현,강성은,강성은,202412,[Y]금융기관,구자은매니저,02-3451-9245,kje@ajuib.co.kr,회계반영,2
2293,-,기초자산,"롯데홈쇼핑(구,우리홈쇼핑)펀드(기초자산)",IMMGrowth벤처펀드제1호,재평가,매드업,1101115628156 ,A07,3,-,분기,2024-09-30,2024-11-22,보고서제공X,-,오영석, 0.4 ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
2294,-,기초자산,"롯데홈쇼핑(구,우리홈쇼핑)펀드(기초자산)",IMMGrowth벤처펀드제1호,재평가,매드업,1101115628156 ,A01,0,-,분기,2024-09-30,2024-11-22,보고서제공X,-,오영석, - ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
2304,-,기초자산,"롯데홈쇼핑(구,우리홈쇼핑)펀드(기초자산)",IMMGrowth벤처펀드제1호,재평가,피알앤디컴퍼니,1101115599050 ,A01,3,-,분기,2024-09-30,2024-11-22,보고서제공X,-,변혜진, - ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
2305,-,기초자산,"롯데홈쇼핑(구,우리홈쇼핑)펀드(기초자산)",IMMGrowth벤처펀드제1호,재평가,피알앤디컴퍼니,1101115599050 ,A07,3,-,분기,2024-09-30,2024-11-22,보고서제공X,-,변혜진, - ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
2378,-,개별종목,2024-11-10,티에스인베스트먼트,신규,신사유람단,1101117007697 ,A07,77,-,반기 ,2024-12-31,평가철회,평가철회,-,최수민, - ,오수현,유재호,유재호,평가철회,평가철회,임혁빈부장,"02-6250-5705, 010-2247-5835",imhb@tsinvestment.co.kr,LP제출,2
2441,평가최종값 : 2024-12-31,개별종목,2024-11-11,NAVER-KTB오디오콘텐츠전문투자조합,재평가,"테라바이트랩스(구,테라바이트)",1101114183101 ,A07,0,-,연말,2024-12-31,2024-12-16,2025-01-17,-,김에스더, 1.0 ,오수현,유재호,유재호,202412,[D]KTB그룹,이현욱대리,"031-628-6420, 010-2765-9167",hwklee@daolinvestment.com,-,2
2684,-,기초자산,"하이브,Krust Universe Pte- Ltd-펀드(기초자산)",해시드벤처투자조합2호,재평가,Borderless Investing Inc.,KBP2022120168,D02,0,-,분기,2024-09-30,2024-12-13,보고서제공X,-,서동현, - ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
2716,-,기초자산,"하이브,Krust Universe Pte- Ltd-펀드(기초자산)",해시드벤처투자조합2호,재평가,LOVO Inc.,KBP2022120182,A05,0,-,분기,2024-09-30,2024-12-13,보고서제공X,-,정재형, 0.4 ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
2728,-,기초자산,"하이브,Krust Universe Pte- Ltd-펀드(기초자산)",해시드벤처투자조합2호,재평가,Dolores Park Labs Incorporated,KBP2023060055,D06,0,-,분기,2024-09-30,2024-12-13,보고서제공X,-,신원준, - ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
2747,-,개별종목,2024-11-13,국민연금직접투자,재평가,미시령동서관통도로,1401110014396 ,B05,0,-,년,2024-09-30,2024-11-29,2024-11-29,-,신원준, 1.0 ,오수현,이현승,이현승,202411,[Y]금융기관,0,0,0,국민연금제출,2
2775,-,기초자산,"유진자산운용,유진투자증권,IBK연금보험펀드(기초자산)",유진에버베스트턴어라운드기업재무안정사모투자전문회사,재평가,테크스퀘어,1341110150784 ,D02,0,-,분기 ,2024-12-31,2024-12-16,보고서제공X,-,이진주, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
2776,-,기초자산,"유진자산운용,유진투자증권,IBK연금보험펀드(기초자산)",유진에버베스트턴어라운드기업재무안정사모투자전문회사,재평가,테크스퀘어,1341110150784 ,A07,0,-,분기 ,2024-12-31,2024-12-16,보고서제공X,-,이진주, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
2777,-,기초자산,"유진자산운용,유진투자증권,IBK연금보험펀드(기초자산)",유진에버베스트턴어라운드기업재무안정사모투자전문회사,재평가,테크스퀘어,1341110150784 ,D02,1,-,분기 ,2024-12-31,2024-12-16,보고서제공X,-,이진주, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
2778,-,기초자산,"유진자산운용,유진투자증권,IBK연금보험펀드(기초자산)",유진에버베스트턴어라운드기업재무안정사모투자전문회사,재평가,테크스퀘어,1341110150784 ,A07,1,-,분기 ,2024-12-31,2024-12-16,보고서제공X,-,이진주, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
2862,-,개별종목,2024-11-15,교보자산신탁,재평가,대윤디앤씨,2802110218046 ,A01,0,-,년,2024-11-30,2024-12-18,2024-12-26,-,강성은, 0.2 ,김수현,김영하,김영하,202411,[Y]금융기관,박성희차장,02-3404-3454,neosh@kyobotrust.co.kr,회계반영,2
2946,-,기초자산,에너지인프라자산운용펀드(기초자산),마그나e-신산업펀드,신규,프렘투,1717110172947 ,A07,1,-,미정,2024-12-31,2024-12-20,보고서제공X,-,강성은, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
2953,-,기초자산,네오위즈홀딩스펀드(기초자산),스마트대한민국라구나비대면펀드제4호,신규,아이디어허브,1101116239407 ,A05,1,-,연말,2024-09-30,2024-11-29,보고서제공X,-,원정우, - ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
2954,-,기초자산,네오위즈홀딩스펀드(기초자산),스마트대한민국라구나비대면펀드제4호,신규,아이디어허브,1101116239407 ,A07,3,-,연말,2024-09-30,2024-11-29,보고서제공X,-,원정우, - ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
2964,-,기초자산,네오위즈홀딩스펀드(기초자산),스마트대한민국라구나비대면펀드제4호,신규,셀레브레인,1601110480618 ,A01,0,-,연말,2024-09-30,2024-11-29,보고서제공X,-,정은채, - ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
2979,-,기초자산,네오위즈홀딩스펀드(기초자산),스마트대한민국라구나비대면펀드제4호,신규,오늘의웹툰,1101117728483 ,A07,77,-,연말,2024-09-30,2024-11-29,보고서제공X,-,서동현, - ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
3175,-,기초자산,오디텍펀드(기초자산),티에스14호뉴딜혁신투자조합,재평가,신사유람단,1101117007697 ,A07,0,-,연말,2024-12-31,2025-01-13,보고서제공X,-,최수민, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
3577,-,기초자산,유진투자증권펀드(기초자산),2015KIF-스톤브릿지IT전문투자조합,재평가,매드업,1101115628156 ,A07,1,-,반기 ,2024-12-31,2025-01-06,보고서제공X,-,오영석, 0.4 ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
3578,-,기초자산,유진투자증권펀드(기초자산),2015KIF-스톤브릿지IT전문투자조합,재평가,매드업,1101115628156 ,A01,0,-,반기 ,2024-12-31,2025-01-06,보고서제공X,-,오영석, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
3592,-,기초자산,유진투자증권펀드(기초자산),2015KIF-스톤브릿지IT전문투자조합,재평가,매드업,1101115628156 ,A07,2,-,반기 ,2024-12-31,2025-01-06,보고서제공X,-,오영석, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
3599,-,기초자산,유진투자증권펀드(기초자산),"에코리아사모투자(구,아이엠엠인베스트먼트5호사모투자)",재평가,신대한정유산업,1244110022442 ,A01,0,-,반기 ,2024-12-31,2025-01-06,보고서제공X,-,서경덕, 0.4 ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
3707,-,기초자산,유진투자증권펀드(기초자산),SGI유니콘스타트업투자조합,재평가,"Hongsheng Sciences HK Limited(구,Cytovant Sciences HK Ltd.)",KBP2021110048,A05,0,-,반기 ,2024-12-31,2025-01-06,보고서제공X,-,김영하, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
3713,-,기초자산,유진투자증권펀드(기초자산),스마트대한민국KT넥스트투자조합,재평가,쓰리제이,1101117555125 ,A07,0,-,반기 ,2024-12-31,2025-01-06,보고서제공X,-,강성은, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
3714,-,기초자산,유진투자증권펀드(기초자산),스마트대한민국KT넥스트투자조합,재평가,쓰리제이,1101117555125 ,D06,0,-,반기 ,2024-12-31,2025-01-06,보고서제공X,-,강성은, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
3730,-,기초자산,유진투자증권펀드(기초자산),이지스현대차증권프롭테크신기술조합,재평가,스파크펫,1101117313416 ,A05,0,-,반기 ,2024-12-31,2025-01-06,보고서제공X,-,이현승, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
3757,-,기초자산,유진투자증권펀드(기초자산),앰버스톤제1호사모투자,재평가,Ambertone HK Two Limited,KBP2022120270,A01,0,-,반기 ,2024-12-31,2025-01-06,보고서제공X,-,유재호, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
3790,-,개별종목,2024-11-22,보광산업,재평가,홈센타홀딩스,1760110003901 ,D02,4,-,반기,2024-12-31,평가철회,평가철회,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,평가철회,평가철회,도선규부장,053-210-5138,dsk@home-center.co.kr,회계반영,0
3865,-,개별종목,2024-11-25,메디톡스,재평가,노벨티노빌리티,1358110324061 ,A01,0,-,년,2024-09-30,2024-12-12,2024-12-15,-,신원준, 1.0 ,오수현,서동현,서동현,202411,[X]일반기업,채종운차장,"02-6901-5809, 010-2929-3971 ",chaejw@medytox.com ,회계반영 ,2
3867,-,개별종목,2024-11-25,메디톡스,재평가,노벨티노빌리티,1358110324061 ,A07,2,-,년,2024-09-30,2024-12-12,2024-12-15,-,신원준, - ,오수현,서동현,서동현,202411,[X]일반기업,채종운차장,"02-6901-5809, 010-2929-3971 ",chaejw@medytox.com ,회계반영 ,2
3868,-,개별종목,2024-11-25,메디톡스,재평가,노벨티노빌리티,1358110324061 ,A07,1,-,년,2024-09-30,2024-12-12,2024-12-15,-,신원준, - ,오수현,서동현,서동현,202411,[X]일반기업,채종운차장,"02-6901-5809, 010-2929-3971 ",chaejw@medytox.com ,회계반영 ,2
4057,-,기초자산,삼성화재펀드(기초자산),에이티넘고성장기업투자조합,재평가,BC hSensor Limited,KBP2019090001,A07,0,-,분기,2024-12-31,평가철회,평가철회,-,이진주, - ,조현우,-,-,평가철회,평가철회,0,0,0,-,0
4059,-,기초자산,삼성화재펀드(기초자산),에이티넘고성장기업투자조합,재평가,두나무,1101114834853 ,A01,0,-,분기,2024-12-31,평가철회,평가철회,-,최수민, - ,김수현,-,-,평가철회,평가철회,0,0,0,-,0
4060,-,기초자산,삼성화재펀드(기초자산),에이티넘고성장기업투자조합,재평가,디디에스,2301110157353 ,A07,2,-,분기,2024-12-31,평가철회,평가철회,-,채동우, - ,채동우,-,-,평가철회,평가철회,0,0,0,-,0
4066,-,기초자산,삼성화재펀드(기초자산),에이티넘고성장기업투자조합,재평가,"씨피랩스(구,코인플러그)",1311110354909 ,A07,3,-,분기,2024-12-31,평가철회,평가철회,-,정은채, - ,정은채,-,-,평가철회,평가철회,0,0,0,-,0
4068,-,기초자산,삼성화재펀드(기초자산),에이티넘고성장기업투자조합,재평가,클로버추얼패션,1101114032465 ,A01,0,-,분기,2024-12-31,평가철회,평가철회,-,이상민, - ,김예림,-,-,평가철회,평가철회,0,0,0,-,0
4069,-,기초자산,삼성화재펀드(기초자산),에이티넘고성장기업투자조합,재평가,"위메이드커넥트(구,플레로게임즈)",1101113679143 ,A01,0,-,분기,2024-12-31,평가철회,평가철회,-,이현승, - ,이현승,-,-,평가철회,평가철회,0,0,0,-,0
4070,-,기초자산,삼성화재펀드(기초자산),에이티넘고성장기업투자조합,재평가,CAN LAB PTE. LTD.,KBP2021120239,A01,0,-,분기,2024-12-31,평가철회,평가철회,-,오영석, - ,서수빈,-,-,평가철회,평가철회,0,0,0,-,0
4110,-,기초자산,삼성화재펀드(기초자산),한국투자Re-Up펀드,재평가,구하다,1101117055456 ,A07,0,-,분기,2024-12-31,2025-01-06,보고서제공X,-,이현승, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
4115,-,기초자산,삼성화재펀드(기초자산),한국투자Re-Up펀드,재평가,라메디텍,1101114778316 ,A01,0,-,분기,2024-12-31,평가철회,평가철회,-,상장, - ,김수현,-,-,평가철회,평가철회,0,0,0,-,0
4116,-,기초자산,삼성화재펀드(기초자산),한국투자Re-Up펀드,재평가,로이비쥬얼,1101113015339 ,A07,1,-,분기,2024-12-31,2025-01-06,보고서제공X,-,강승현, 0.4 ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
4117,-,기초자산,삼성화재펀드(기초자산),한국투자Re-Up펀드,재평가,로이비쥬얼,1101113015339 ,A01,0,-,분기,2024-12-31,2025-01-06,보고서제공X,-,강승현, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
4121,-,기초자산,삼성화재펀드(기초자산),한국투자Re-Up펀드,재평가,바이오인프라생명과학,1246110241808 ,A07,0,-,분기,2024-12-31,평가철회,평가철회,-,김에스더, - ,김수현,-,-,평가철회,평가철회,0,0,0,-,0
4122,-,기초자산,삼성화재펀드(기초자산),한국투자Re-Up펀드,재평가,바이오인프라생명과학,1246110241808 ,A01,0,-,분기,2024-12-31,평가철회,평가철회,-,김에스더, - ,김수현,-,-,평가철회,평가철회,0,0,0,-,0
4124,-,기초자산,삼성화재펀드(기초자산),한국투자Re-Up펀드,재평가,빅씽크,1101116148054 ,A01,0,-,분기,2024-12-31,2025-01-06,보고서제공X,-,이문수, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
4138,-,기초자산,삼성화재펀드(기초자산),한국투자Re-Up펀드,재평가,오늘식탁,1101116336336 ,A07,0,-,분기,2024-12-31,평가철회,평가철회,-,신원준, - ,조현우,-,-,평가철회,평가철회,0,0,0,-,0
4148,-,기초자산,삼성화재펀드(기초자산),한국투자Re-Up펀드,재평가,지투지바이오,1601110451528 ,A07,1,-,분기,2024-12-31,평가철회,평가철회,-,서동현, - ,서동현,-,-,평가철회,평가철회,0,0,0,-,0
4149,-,기초자산,삼성화재펀드(기초자산),한국투자Re-Up펀드,재평가,지투지바이오,1601110451528 ,A07,2,-,분기,2024-12-31,평가철회,평가철회,-,서동현, - ,서동현,-,-,평가철회,평가철회,0,0,0,-,0
4153,-,기초자산,삼성화재펀드(기초자산),한국투자Re-Up펀드,재평가,크라우드웍스,1101116384963 ,A07,1,-,분기,2024-12-31,평가철회,평가철회,-,상장, - ,김예림,-,-,평가철회,평가철회,0,0,0,-,0
4162,-,기초자산,삼성화재펀드(기초자산),한국투자Re-Up펀드,재평가,"휴온스푸디언스(구,휴온스네이처)",1642110013489 ,A07,0,-,분기,2024-12-31,평가철회,평가철회,-,백형진, 0.4 ,백형진,-,-,평가철회,평가철회,0,0,0,-,0
4196,-,기초자산,삼성화재펀드(기초자산),에이티넘성장투자조합2018,재평가,로이비쥬얼,1101113015339 ,A01,0,-,분기,2024-12-31,2025-01-06,보고서제공X,-,강승현, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
4199,-,기초자산,삼성화재펀드(기초자산),에이티넘성장투자조합2018,재평가,로이비쥬얼,1101113015339 ,A07,2,-,분기,2024-12-31,2025-01-06,보고서제공X,-,강승현, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
4220,-,기초자산,삼성화재펀드(기초자산),LB유망벤처산업펀드,재평가,뮬라,1201110667602 ,A07,2,-,분기,2024-12-31,2025-01-06,보고서제공X,-,백형진, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
4250,23년 4분기 평가예정,기초자산,"삼성화재,교보생명보험,코오롱인베스트먼트,현대해상펀드(기초자산)",코오롱2021이노베이션투자조합,재평가,셀레브레인,1601110480618 ,A01,0,-,분기,2024-12-31,2024-12-13,보고서제공X,-,정은채, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
4257,24년 1분기 평가예정,기초자산,"삼성화재,교보생명보험,코오롱인베스트먼트,현대해상펀드(기초자산)",코오롱2021이노베이션투자조합,재평가,피알앤디컴퍼니,1101115599050 ,A07,0,-,분기,2024-12-31,2024-12-13,보고서제공X,-,변혜진, 0.4 ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
4267,24년 2분기 평가예정,기초자산,"삼성화재,교보생명보험,코오롱인베스트먼트,현대해상펀드(기초자산)",코오롱2021이노베이션투자조합,재평가,푸드노트서비스,1101117067097 ,A07,0,-,분기,2024-12-31,2024-12-13,보고서제공X,-,채동우, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
4335,-,기초자산,"삼성화재,롯데손해보험(운용지원팀)펀드(기초자산)",페트라7호사모투자,재평가,지에스아이티엠,1101113451731 ,A07,0,-,분기 ,2024-12-31,2024-12-20,보고서제공X,-,김예림, 0.4 ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
4336,-,기초자산,"삼성화재,롯데손해보험(운용지원팀)펀드(기초자산)",페트라7호사모투자,재평가,지에스아이티엠,1101113451731 ,A01,0,-,분기 ,2024-12-31,2024-12-20,보고서제공X,-,김예림, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
4347,-,기초자산,"삼성화재,현대해상펀드(기초자산)",아주좋은벤처펀드2.0,재평가,"Carbon Biosciences, Inc.",KBP2022030098,A05,0,-,분기 ,2024-12-31,2024-12-20,보고서제공X,-,백형진, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
4348,-,기초자산,"삼성화재,현대해상펀드(기초자산)",아주좋은벤처펀드2.0,재평가,"Carbon Biosciences, Inc.",KBP2022030098,D02,0,-,분기 ,2024-12-31,2024-12-20,보고서제공X,-,백형진, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
4349,-,기초자산,"삼성화재,현대해상펀드(기초자산)",아주좋은벤처펀드2.0,재평가,"Carbon Biosciences, Inc.",KBP2022030098,D02,1,-,분기 ,2024-12-31,2024-12-20,보고서제공X,-,백형진, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
4414,-,기초자산,"삼성화재,현대해상펀드(기초자산)",아주좋은벤처펀드2.0,재평가,하나옵트로닉스,1648110117700 ,A07,0,-,분기 ,2024-12-31,2024-12-20,보고서제공X,-,강승현, 0.4 ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
4747,값송부 : 2024-01-06(오전),기초자산,삼성생명펀드(기초자산),제60호삼성생명신기술사업투자조합,재평가,"GENOME INSIGHT, Inc.",KBP2023120126,A04,0,-,분기,2024-12-31,2025-01-06,보고서제공X,-,원정우, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
4778,-,기초자산,미래컴퍼니펀드(기초자산),쿼드콜라보오퍼스원포스텍창업벤처전문사모투자,재평가,펨토바이오메드,1717110094696 ,A07,0,-,연말,2024-12-31,2025-01-15,보고서제공X,-,신원준, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
4976,-,기초자산,한화생명보험펀드(기초자산),컴퍼니케이-교원창업초기펀드,재평가,에이펀인터렉티브,1101116339710 ,A07,0,-,분기,2024-12-31,2024-12-13,보고서제공X,-,김에스더, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
5007,-,기초자산,한화생명보험펀드(기초자산),해시드벤처투자조합2호,재평가,Borderless Investing Inc.,KBP2022120168,D02,0,-,분기,2024-12-31,2024-12-13,보고서제공X,-,서동현, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
5036,-,기초자산,한화생명보험펀드(기초자산),해시드벤처투자조합2호,재평가,LOVO Inc.,KBP2022120182,A05,0,-,분기,2024-12-31,2024-12-13,보고서제공X,-,정재형, 0.4 ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
5048,-,기초자산,한화생명보험펀드(기초자산),해시드벤처투자조합2호,재평가,Dolores Park Labs Incorporated,KBP2023060055,D06,0,-,분기,2024-12-31,2024-12-13,보고서제공X,-,신원준, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
5190,-,기초자산,"교보생명보험,현대해상펀드(기초자산)",케이비메자닌캐피탈제4호사모투자,재평가,"HyAxiom, Inc.",KBP2023090024,A05,0,-,분기,2024-12-31,2024-12-13,보고서제공X,-,김예림, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
5279,-,기초자산,교보생명보험펀드(기초자산),SV Scale up 펀드,재평가,논스게이트웨이,1101117949435 ,A07,0,-,분기,2024-12-31,2024-12-13,보고서제공X,-,최수민, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
5368,-,기초자산,교보생명보험펀드(기초자산),에스비아이크로스보더어드밴티지펀드,재평가,보노톡스,1101115904845 ,A07,1,-,분기,2024-12-31,2024-12-13,보고서제공X,-,김영하, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
5414,-,기초자산,교보생명보험펀드(기초자산),퓨처플레이신한테크이노베이션제2호,재평가,클레,1101118089777 ,A05,0,-,분기,2024-12-31,2024-12-13,보고서제공X,-,강승현, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
5432,-,기초자산,교보생명보험펀드(기초자산),퓨처플레이신한테크이노베이션제2호,재평가,XL8 Inc.,KBP2022110028,D06,2,-,분기,2024-12-31,2024-12-13,보고서제공X,-,이상민, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
5433,-,기초자산,교보생명보험펀드(기초자산),퓨처플레이신한테크이노베이션제2호,재평가,XL8 Inc.,KBP2022110028,D06,3,-,분기,2024-12-31,2024-12-13,보고서제공X,-,이상민, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
5447,24년 3분기 평가예정,기초자산,"교보생명보험,미래에셋생명보험펀드(기초자산)",한국투자Re-upII펀드,재평가,티큐브잇,1647110091302 ,A07,0,-,분기,2024-12-31,2024-12-13,보고서제공X,-,정재형, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
5472,-,기초자산,"교보생명보험,미래에셋생명보험펀드(기초자산)",한국투자Re-upII펀드,재평가,바이옴에이츠,1101118282206 ,A07,0,-,분기,2024-12-31,2024-12-13,보고서제공X,-,원정우, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
5483,-,기초자산,"교보생명보험,미래에셋생명보험펀드(기초자산)",한국투자Re-upII펀드,재평가,엑소코바이오,1341110458170 ,A01,0,-,분기,2024-12-31,2024-12-13,보고서제공X,-,오영석, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
5501,-,기초자산,"교보생명보험,미래에셋생명보험펀드(기초자산)",한국투자Re-upII펀드,재평가,로이비쥬얼,1101113015339 ,A07,0,-,분기,2024-12-31,2024-12-13,보고서제공X,-,강승현, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
5519,-,기초자산,"교보생명보험,미래에셋생명보험펀드(기초자산)",한국투자Re-upII펀드,재평가,펨토바이오메드,1717110094696 ,A07,0,-,분기,2024-12-31,2024-12-13,보고서제공X,-,신원준, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
5525,-,기초자산,"교보생명보험,미래에셋생명보험펀드(기초자산)",한국투자Re-upII펀드,재평가,아미팜,1101113162346 ,A07,0,-,분기,2024-12-31,2024-12-13,보고서제공X,-,변혜진, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
5941,-,기초자산,"KDB생명보험(지분증권),현대해상펀드(기초자산)",페트라8호사모투자,재평가,헬리녹스,1101115221794 ,A05,0,-,분기 ,2024-12-31,2024-12-20,보고서제공X,-,이진주, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
5955,-,기초자산,"KDB생명보험(지분증권),현대해상펀드(기초자산)",페트라8호사모투자,재평가,헬리녹스,1101115221794 ,A05,1,-,분기 ,2024-12-31,2024-12-20,보고서제공X,-,이진주, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
6130,-,개별종목,2024-11-27,동양,재평가,유진더블유사모투자,1101130031847 ,B01,2,-,연말,2024-12-31,2025-01-02,2025-01-09,-,김영하, - ,김영하,정은채,정은채,202412,[X]일반기업,하정훈차장,010-8929-2281,unghoon.ha@tongyanginc.co.kr,-,0
6174,SPC,기초자산,무림캐피탈펀드(기초자산),제이앤제1호사모투자,재평가,하운드,1101118779344 ,A07,0,-,연말,2024-12-31,2025-01-07,보고서제공X,-,윤광일, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
6178,SPC,기초자산,무림캐피탈펀드(기초자산),제이앤제1호사모투자,재평가,갤럭시미디어,1101118270970 ,A04,0,-,연말,2024-12-31,2025-01-07,보고서제공X,-,윤광일, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
6192,SPC,기초자산,무림캐피탈펀드(기초자산),제이앤제1호사모투자,재평가,솔라홀딩스,1101118953914 ,A01,0,-,연말,2024-12-31,2025-01-07,보고서제공X,-,윤광일, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
6258,-,기초자산,신영증권펀드(기초자산),경기-퀀텀&코리아오메가Follow-on슈퍼맨투자,재평가,하플사이언스,1311110537282 ,A07,1,-,분기,2024-12-31,2025-01-03,보고서제공X,-,김에스더, 0.4 ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
6820,-,기초자산,KB손해보험펀드(기초자산),한국투자글로벌제약산업육성사모투자전문회사,재평가,덴플렉스,2850110297627 ,A07,0,-,분기,2024-12-31,2024-12-10,보고서제공X,-,심태진, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
6831,-,기초자산,KB손해보험펀드(기초자산),페트라6호사모투자,재평가,신대한정유산업,1244110022442 ,A01,0,-,분기 ,2024-12-31,2024-12-10,보고서제공X,-,서경덕, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
6833,-,기초자산,KB손해보험펀드(기초자산),프랙시스밸류크리에이션사모투자,재평가,매드업,1101115628156 ,A01,0,-,분기,2024-12-31,2024-12-10,보고서제공X,-,오영석, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
6834,-,기초자산,KB손해보험펀드(기초자산),프랙시스밸류크리에이션사모투자,재평가,매드업,1101115628156 ,A07,0,-,분기,2024-12-31,2024-12-10,보고서제공X,-,오영석, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
6871,-,기초자산,KB손해보험펀드(기초자산),디에스씨홈런펀드제1호,재평가,포트래이,1101117966439 ,A07,0,-,분기,2024-12-31,2024-12-10,보고서제공X,-,정은채, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
6890,-,기초자산,KB손해보험펀드(기초자산),디에스씨홈런펀드제1호,재평가,"GENOME INSIGHT, Inc.",KBP2023120126,A05,1,-,분기,2024-12-31,2024-12-10,보고서제공X,-,원정우, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
6891,-,기초자산,KB손해보험펀드(기초자산),디에스씨홈런펀드제1호,재평가,에버온,1101115000081 ,A07,0,-,분기,2024-12-31,2024-12-10,보고서제공X,-,정재형, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
7215,"2차평가값 : 2025-01-17, 최종평가값 : 2025-01-24",개별종목,2024-11-29,과학기술인공제회(수익증권),신규,오스템임플란트,1101111361669 ,E01,1,-,연말,2024-12-31,2025-01-10,2025-02-05,-,대체평가3사업본부, - ,대체평가3사업본부,김영규,김영규,202412,[T]기타보험기관[1본부],리스크기획실전지현,0,jjh900522@sema.or.kr,-,0
7216,"2차평가값 : 2025-01-17, 최종평가값 : 2025-01-24",개별종목,2024-11-29,과학기술인공제회(수익증권),신규,오스템임플란트,1101111361669 ,E01,2,-,연말,2024-12-31,2025-01-10,2025-02-05,-,대체평가3사업본부, - ,대체평가3사업본부,김영규,김영규,202412,[T]기타보험기관[1본부],리스크기획실전지현,0,jjh900522@sema.or.kr,-,0
7218,"2차평가값 : 2025-01-17, 최종평가값 : 2025-01-24",개별종목,2024-11-29,과학기술인공제회(수익증권),신규,쌍용씨앤이,1101110037823 ,E01,2,-,연말,2024-12-31,2025-01-10,2025-02-05,-,대체평가3사업본부, - ,대체평가3사업본부,김영규,김영규,202412,[T]기타보험기관[1본부],리스크기획실전지현,0,jjh900522@sema.or.kr,-,0
7259,-,기초자산,과학기술인공제회펀드(기초자산),스카이레이크에쿼티제1호사모투자,재평가,SKYLAKE EQUITY INVESTMENT II S.A.R.L,KBP2022030094,A01,0,-,연말,2024-12-31,2025-01-10,보고서제공X,-,윤광일, 0.4 ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
7309,-,기초자산,"미래에셋생명(지분증권),삼성증권(PM팀)(구,전략투자팀)펀드(기초자산)",IMMGrowth벤처펀드제1호,재평가,매드업,1101115628156 ,A07,3,-,분기,2024-12-31,2025-01-06,보고서제공X,-,오영석, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
7310,-,기초자산,"미래에셋생명(지분증권),삼성증권(PM팀)(구,전략투자팀)펀드(기초자산)",IMMGrowth벤처펀드제1호,재평가,매드업,1101115628156 ,A01,0,-,분기,2024-12-31,2025-01-06,보고서제공X,-,오영석, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
7320,-,기초자산,"미래에셋생명(지분증권),삼성증권(PM팀)(구,전략투자팀)펀드(기초자산)",IMMGrowth벤처펀드제1호,재평가,피알앤디컴퍼니,1101115599050 ,A01,3,-,분기,2024-12-31,2025-01-06,보고서제공X,-,변혜진, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
7321,-,기초자산,"미래에셋생명(지분증권),삼성증권(PM팀)(구,전략투자팀)펀드(기초자산)",IMMGrowth벤처펀드제1호,재평가,피알앤디컴퍼니,1101115599050 ,A07,3,-,분기,2024-12-31,2025-01-06,보고서제공X,-,변혜진, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
7334,-,기초자산,미래에셋생명(지분증권)펀드(기초자산),미래에셋-현대중공업지주신성장투자조합1호,재평가,매직불릿테라퓨틱스,1101118283957 ,A07,0,-,분기,2024-12-31,2025-01-06,보고서제공X,-,유재호, 0.4 ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
7452,"본평가 : 2025-01-03, 세부편입자산리스트 : 2025-01-15",개별종목,2024-11-29,"DB손해보험(구,동부화재해상)",재평가,린드먼아시아투자조합16호,KBP2022120021,B01,0,-,분기,2024-12-31,2024-12-16,2025-01-15,-,이진주, 1.0 ,오수현,서동현/조용원,서동현/조용원,202412,[T]기타보험기관[1본부],민세홍책임,02-331-5464,sehong@dbins.co.kr,-,2
7475,-,기초자산,"DB손해보험(구,동부화재해상)펀드(기초자산)",IMM세컨더리벤처펀드5호,재평가,아이디어허브,1101116239407 ,A07,0,-,분기 ,2024-12-31,평가철회,평가철회,-,원정우, - ,오수현,-,-,평가철회,평가철회,0,0,0,-,2
7482,-,기초자산,"DB손해보험(구,동부화재해상)펀드(기초자산)",IMM세컨더리벤처펀드5호,재평가,아이디어허브,1101116239407 ,A07,1,-,분기 ,2024-12-31,평가철회,평가철회,-,원정우, - ,오수현,-,-,평가철회,평가철회,0,0,0,-,2
7541,-,기초자산,"DB손해보험(구,동부화재해상)펀드(기초자산)",에이티넘성장투자조합2023,재평가,피알앤디컴퍼니,1101115599050 ,A07,3,-,분기,2024-12-31,2024-12-16,보고서제공X,-,변혜진, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
7590,-,기초자산,"DB손해보험(구,동부화재해상)펀드(기초자산)",KDBC-K22023세컨더리투자조합,재평가,엑소코바이오,1341110458170 ,A01,0,-,분기,2024-12-31,2024-12-16,보고서제공X,-,오영석, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
7601,-,기초자산,"DB손해보험(구,동부화재해상)펀드(기초자산)",디에스씨세컨더리패키지인수펀드제1호,재평가,피알앤디컴퍼니,1101115599050 ,A07,5,-,분기,2024-12-31,2024-12-16,보고서제공X,-,변혜진, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
7602,-,기초자산,"DB손해보험(구,동부화재해상)펀드(기초자산)",디에스씨세컨더리패키지인수펀드제1호,재평가,피알앤디컴퍼니,1101115599050 ,A01,0,-,분기,2024-12-31,2024-12-16,보고서제공X,-,변혜진, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
8249,-,기초자산,코오롱인베스트먼트펀드(기초자산),코오롱2017신산업육성투자조합,재평가,에이피트바이오,1101116955003 ,A07,0,-,연말,2024-12-31,2025-01-10,보고서제공X,-,이진주, 0.4 ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
8260,-,기초자산,코오롱인베스트먼트펀드(기초자산),코오롱20174차산업혁명투자조합,재평가,피알앤디컴퍼니,1101115599050 ,A07,11,-,연말,2024-12-31,2025-01-10,보고서제공X,-,변혜진, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
8269,-,기초자산,코오롱인베스트먼트펀드(기초자산),코오롱20174차산업혁명투자조합,재평가,에이피트바이오,1101116955003 ,A07,0,-,연말,2024-12-31,2025-01-10,보고서제공X,-,이진주, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
8277,-,기초자산,코오롱인베스트먼트펀드(기초자산),코오롱20174차산업혁명투자조합,재평가,"Hongsheng Sciences HK Limited(구,Cytovant Sciences HK Ltd.)",KBP2021110048,A05,0,-,연말,2024-12-31,2025-01-10,보고서제공X,-,김영하, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
8288,-,기초자산,코오롱인베스트먼트펀드(기초자산),코오롱20174차산업혁명투자조합,재평가,에이피트바이오,1101116955003 ,A07,1,-,연말,2024-12-31,2025-01-10,보고서제공X,-,이진주, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
8309,-,기초자산,코오롱인베스트먼트펀드(기초자산),코오롱2019유니콘투자조합,재평가,에이피트바이오,1101116955003 ,A07,0,-,연말,2024-12-31,2025-01-10,보고서제공X,-,이진주, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
8321,-,기초자산,코오롱인베스트먼트펀드(기초자산),코오롱2019유니콘투자조합,재평가,피알앤디컴퍼니,1101115599050 ,A07,0,-,연말,2024-12-31,2025-01-10,보고서제공X,-,변혜진, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
8418,-,기초자산,한국투자증권(기획조정실)펀드(기초자산),한국투자바이오글로벌펀드,재평가,Imel Biotherapeutics,KBP2021120228,A05,0,-,분기,2024-12-31,2025-01-06,보고서제공X,-,이문수, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
8432,-,기초자산,한국투자증권(기획조정실)펀드(기초자산),한국투자바이오글로벌펀드,재평가,덴플렉스,2850110297627 ,A07,0,-,분기,2024-12-31,2025-01-06,보고서제공X,-,심태진, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
8454,-,기초자산,한국투자증권(기획조정실)펀드(기초자산),한국투자바이오글로벌펀드,재평가,브이에스아이,1355110266772 ,A07,0,-,분기,2024-12-31,평가철회,평가철회,-,김예림, - ,오수현,-,-,평가철회,평가철회,0,0,0,-,2
8461,-,기초자산,한국투자증권(기획조정실)펀드(기초자산),한국투자바이오글로벌펀드,재평가,스토리티비,1101114459073 ,A01,0,-,분기,2024-12-31,2025-01-06,보고서제공X,-,채동우, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
8462,-,기초자산,한국투자증권(기획조정실)펀드(기초자산),한국투자바이오글로벌펀드,재평가,스토리티비,1101114459073 ,A07,0,-,분기,2024-12-31,2025-01-06,보고서제공X,-,채동우, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
8466,-,기초자산,한국투자증권(기획조정실)펀드(기초자산),한국투자바이오글로벌펀드,재평가,아미팜,1101113162346 ,A07,0,-,분기,2024-12-31,2025-01-06,보고서제공X,-,변혜진, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
8467,-,기초자산,한국투자증권(기획조정실)펀드(기초자산),한국투자바이오글로벌펀드,재평가,아미팜,1101113162346 ,A01,0,-,분기,2024-12-31,2025-01-06,보고서제공X,-,변혜진, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
8522,-,기초자산,한국투자증권(기획조정실)펀드(기초자산),한국투자바이오글로벌펀드,재평가,필드큐어,1101116540490 ,A07,0,-,분기,2024-12-31,2025-01-06,보고서제공X,-,심태진, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
8525,-,기초자산,한국투자증권(기획조정실)펀드(기초자산),한국투자바이오글로벌펀드,재평가,휴마트컴퍼니,1101115939959 ,A07,0,-,분기,2024-12-31,2025-01-06,보고서제공X,-,오영석, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
8542,-,기초자산,한국투자증권(기획조정실)펀드(기초자산),한국투자바이오글로벌펀드,재평가,필드큐어,1101116540490 ,A07,1,-,분기,2024-12-31,2025-01-06,보고서제공X,-,심태진, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
8748,"2차평가값 : 2024-12-23, 최종평가값 : 2024-12-31",개별종목,2024-12-03,KB인베스트먼트,재평가,아퓨어스,1159110054727 ,A01,0,-,분기 ,2024-12-31,2024-12-19,2025-01-10,2025-01-17,심태진, 1.0 ,오수현,최수민,최수민,202412,[Y]금융기관,경영기획그룹곽예은계장 ,02-3015-4782 ,ye.kwak@kbfg.com ,-,2
9045,-,기초자산,현대해상펀드(기초자산),한국투자유망서비스산업투자조합,재평가,로이비쥬얼,1101113015339 ,A07,0,-,분기 ,2024-12-31,2024-12-20,보고서제공X,-,강승현, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
9046,-,기초자산,현대해상펀드(기초자산),한국투자유망서비스산업투자조합,재평가,로이비쥬얼,1101113015339 ,A01,0,-,분기 ,2024-12-31,2024-12-20,보고서제공X,-,강승현, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
9054,-,기초자산,현대해상펀드(기초자산),제이케이엘제10호사모투자,재평가,지에스아이티엠,1101113451731 ,A07,0,-,분기 ,2024-12-31,2024-12-20,보고서제공X,-,김예림, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
9055,-,기초자산,현대해상펀드(기초자산),제이케이엘제10호사모투자,재평가,지에스아이티엠,1101113451731 ,A01,0,-,분기 ,2024-12-31,2024-12-20,보고서제공X,-,김예림, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
9130,-,기초자산,현대해상펀드(기초자산),DSC초기기업성장지원펀드,재평가,하플사이언스,1311110537282 ,A07,0,-,분기 ,2024-12-31,2024-12-20,보고서제공X,-,김에스더, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
9158,-,기초자산,현대해상펀드(기초자산),베이비샤크넥스트유니콘IP펀드,재평가,스파이더랩,1101117117313 ,A07,0,-,분기 ,2024-12-31,2025-01-03,보고서제공X,-,이상민, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
9648,-,기초자산,금강철강펀드(기초자산),베이스에이스트링창업벤처전문사모투자,재평가,오늘의웹툰,1101117728483 ,A05,0,-,연말,2024-12-31,2025-01-24,보고서제공X,-,서동현, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
9669,-,기초자산,금강철강펀드(기초자산),베이스에이스트링창업벤처전문사모투자,재평가,오늘의웹툰,1101117728483 ,A05,1,-,연말,2024-12-31,2025-01-24,보고서제공X,-,서동현, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
9718,-,기초자산,한국투자밸류자산운용펀드(기초자산),한국투자SEA-CHINAFund,재평가,로이비쥬얼,1101113015339 ,A07,0,-,분기,2024-12-31,2025-01-07,보고서제공X,-,강승현, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
10016,-,기초자산,롯데카드(메타세컨더리제이호사모투자)펀드(기초자산),얼머스뉴딜서비스투자조합1호,재평가,노벨티노빌리티,1358110324061 ,A07,0,-,반기 ,2024-09-30,2024-12-20,보고서제공X,-,신원준, - ,오수현,-,-,202411,[6]기타기관펀드(기초자산),0,0,0,-,2
10220,-,기초자산,"삼성증권(PM팀)(구,전략투자팀)펀드(기초자산)",2018KIF-프리미어기술금융투자조합,재평가,피알앤디컴퍼니,1101115599050 ,A07,1,-,분기 ,2024-12-31,2025-01-06,보고서제공X,-,변혜진, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
10314,-,기초자산,"삼성증권(PM팀)(구,전략투자팀)펀드(기초자산)",에스비아이-성장사다리코넥스활성화펀드제2호,재평가,엑소코바이오,1341110458170 ,A01,0,-,분기 ,2024-12-31,2025-01-06,보고서제공X,-,오영석, 0.4 ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
10968,-,개별종목,2024-12-18,한화투자증권,신규,PT Ciptadana Capital,KBP2024120214,A01,0,-,연말,2024-12-31,평가철회,평가철회,-,외주용역, - ,신규,-,-,평가철회,평가철회,권대호과장,02-3772-7174,daeho.kwon@hanwha.com,회계반영,0
10969,-,개별종목,2024-12-18,한화투자증권,신규,PT Ciptadana Capital,KBP2024120214,D06,0,-,연말,2024-12-31,평가철회,평가철회,-,외주용역, - ,신규,-,-,평가철회,평가철회,권대호과장,02-3772-7174,daeho.kwon@hanwha.com,회계반영,0
10984,-,개별종목,2024-12-19,KB라이프(LT),재평가,KB팔용터널사모특별자산투자신탁,KBP2016060133,B02,0,-,분기 ,2024-12-31,평가철회,평가철회,-,대체평가3사업본부, - ,대체평가3사업본부,-,-,평가철회,평가철회, , , ,-,0
11742,-,개별종목,2024-12-26,에이아이에이생명보험(수익증권),신규,PineBridge Asia Partners II ,KBP2024120240,B02,0,-,연말,2024-12-31,2025-01-17,2025-01-23,-,대체평가3사업본부, - ,대체평가3사업본부,-,-,202412,[T]기타보험기관[1본부],이성윤차장,02-3707-4894,sungyoon.lee@aia.com,회계반영,0
11743,-,개별종목,2024-12-26,에이아이에이생명보험(수익증권),신규,HPS Mezzanine Partners II ,KBP2024120241,B02,0,-,연말,2024-12-31,2025-01-17,2025-01-23,-,대체평가3사업본부, - ,대체평가3사업본부,-,-,202412,[T]기타보험기관[1본부],이성윤차장,02-3707-4894,sungyoon.lee@aia.com,회계반영,0
11744,-,개별종목,2024-12-26,에이아이에이생명보험(수익증권),신규,GSO Capital Solutions Fund II ,KBP2024120242,B02,0,-,연말,2024-12-31,2025-01-17,2025-01-23,-,대체평가3사업본부, - ,대체평가3사업본부,-,-,202412,[T]기타보험기관[1본부],이성윤차장,02-3707-4894,sungyoon.lee@aia.com,회계반영,0
11745,-,개별종목,2024-12-26,에이아이에이생명보험(수익증권),신규,Primavera Fund III ,KBP2024120243,B02,0,-,연말,2024-12-31,2025-01-17,2025-01-23,-,대체평가3사업본부, - ,대체평가3사업본부,-,-,202412,[T]기타보험기관[1본부],이성윤차장,02-3707-4894,sungyoon.lee@aia.com,회계반영,0
11746,-,개별종목,2024-12-26,에이아이에이생명보험(수익증권),신규,Silver Lake Partners VI ,KBP2024120244,B02,0,-,연말,2024-12-31,2025-01-17,2025-01-23,-,대체평가3사업본부, - ,대체평가3사업본부,-,-,202412,[T]기타보험기관[1본부],이성윤차장,02-3707-4894,sungyoon.lee@aia.com,회계반영,0
11747,-,개별종목,2024-12-26,에이아이에이생명보험(수익증권),신규,Ares Senior Direct Lending Fund III ,KBP2024120245,B02,0,-,연말,2024-12-31,2025-01-17,2025-01-23,-,대체평가3사업본부, - ,대체평가3사업본부,-,-,202412,[T]기타보험기관[1본부],이성윤차장,02-3707-4894,sungyoon.lee@aia.com,회계반영,0
11748,-,개별종목,2024-12-26,에이아이에이생명보험(수익증권),신규,HarbourVest Dover Street XI ,KBP2024120246,B02,0,-,연말,2024-12-31,2025-01-17,2025-01-23,-,대체평가3사업본부, - ,대체평가3사업본부,-,-,202412,[T]기타보험기관[1본부],이성윤차장,02-3707-4894,sungyoon.lee@aia.com,회계반영,0
11749,-,개별종목,2024-12-26,에이아이에이생명보험(수익증권),신규,Ardian Secondary Funds IX ,KBP2024120247,B02,0,-,연말,2024-12-31,2025-01-17,2025-01-23,-,대체평가3사업본부, - ,대체평가3사업본부,-,-,202412,[T]기타보험기관[1본부],이성윤차장,02-3707-4894,sungyoon.lee@aia.com,회계반영,0
11799,-,개별종목,2024-12-30,SK텔레콤,재평가,SK텔레콤,1101110371346 ,D06,0,-,분기 ,2024-12-31,2025-01-03,2025-01-10,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202412,[W]상장기업,조예인매니저,010-8269-1515,y27.cho@sk.com,회계반영,0
11800,-,개별종목,2024-12-30,SK텔레콤,재평가,SK텔레콤,1101110371346 ,D06,1,-,분기 ,2024-12-31,2025-01-03,2025-01-10,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202412,[W]상장기업,조예인매니저,010-8269-1515,y27.cho@sk.com,회계반영,0
11801,-,개별종목,2024-12-30,SK텔레콤,재평가,SK텔레콤,1101110371346 ,D06,2,-,분기 ,2024-12-31,2025-01-03,2025-01-10,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202412,[W]상장기업,조예인매니저,010-8269-1515,y27.cho@sk.com,회계반영,0
11802,-,개별종목,2024-12-30,SK텔레콤,재평가,SK텔레콤,1101110371346 ,D06,3,-,분기 ,2024-12-31,2025-01-03,2025-01-10,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202412,[W]상장기업,조예인매니저,010-8269-1515,y27.cho@sk.com,회계반영,0
11803,-,개별종목,2024-12-30,SK텔레콤,재평가,SK텔레콤,1101110371346 ,D06,4,-,분기 ,2024-12-31,2025-01-03,2025-01-10,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202412,[W]상장기업,조예인매니저,010-8269-1515,y27.cho@sk.com,회계반영,0
11804,-,개별종목,2024-11-22,보광산업,재평가,보광산업,1743110003882 ,D02,4,-,반기,2024-12-31,2025-01-08,2025-01-13,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202412,[W]상장기업,도선규부장,053-210-5138,dsk@home-center.co.kr,회계반영,0
11805,"최종결과송부 : 2024-10-04, 세부편입자산리스트 : 2024-10-17",개별종목,2024-12-31,DB손해보험(수익증권),신규,JB모빌리티전문투자형사모투자신탁1호,KBP2019090125,B02,0,-,분기 ,2024-12-31,2025-01-03,2025-01-15,-,대체평가3사업본부, - ,대체평가3사업본부,서동현/조용원,서동현/조용원,202412,[T]기타보험기관[1본부],박희만 ,02-331-5462 ,parkheeman@dbins.co.kr ,-,0
11806,"최종결과송부 : 2024-10-04, 세부편입자산리스트 : 2024-10-17",개별종목,2024-12-31,DB손해보험(수익증권),신규,트러스톤글로벌인프라전문투자형사모투자신탁제8호,KBP2019120217,B02,0,-,분기 ,2024-12-31,2025-01-03,2025-01-15,-,대체평가3사업본부, - ,대체평가3사업본부,서동현/조용원,서동현/조용원,202412,[T]기타보험기관[1본부],박희만 ,02-331-5462 ,parkheeman@dbins.co.kr ,-,0
11807,"최종결과송부 : 2024-10-04, 세부편입자산리스트 : 2024-10-17",개별종목,2024-12-31,DB손해보험(수익증권),신규,KB컨티넨탈유럽인프라전문투자형사모특별자산투자신탁,KBP2018090008,B02,0,-,분기 ,2024-12-31,2025-01-03,2025-01-15,-,대체평가3사업본부, - ,대체평가3사업본부,서동현/조용원,서동현/조용원,202412,[T]기타보험기관[1본부],박희만 ,02-331-5462 ,parkheeman@dbins.co.kr ,-,0
11808,"최종결과송부 : 2024-10-04, 세부편입자산리스트 : 2024-10-17",개별종목,2024-12-31,DB손해보험(수익증권),신규,KB컨티넨탈유럽인프라전문투자형사모특별자산투자신탁제3호,KBP2019090100,B02,0,-,분기 ,2024-12-31,2025-01-03,2025-01-15,-,대체평가3사업본부, - ,대체평가3사업본부,서동현/조용원,서동현/조용원,202412,[T]기타보험기관[1본부],박희만 ,02-331-5462 ,parkheeman@dbins.co.kr ,-,0
11809,"최종결과송부 : 2024-10-04, 세부편입자산리스트 : 2024-10-17",개별종목,2024-12-31,DB손해보험(수익증권),신규,한화유럽PPP인프라전문투자형사모특별자산신탁1-2호,KBP2019090116,B02,0,-,분기 ,2024-12-31,2025-01-03,2025-01-15,-,대체평가3사업본부, - ,대체평가3사업본부,서동현/조용원,서동현/조용원,202412,[T]기타보험기관[1본부],박희만 ,02-331-5462 ,parkheeman@dbins.co.kr ,-,0
11810,"최종결과송부 : 2024-10-04, 세부편입자산리스트 : 2024-10-17",개별종목,2024-12-31,DB손해보험(수익증권),신규,한화유럽PPP인프라전문투자형사모특별자산신탁1-1호,KBP2019090115,B02,0,-,분기 ,2024-12-31,2025-01-03,2025-01-15,-,대체평가3사업본부, - ,대체평가3사업본부,서동현/조용원,서동현/조용원,202412,[T]기타보험기관[1본부],박희만 ,02-331-5462 ,parkheeman@dbins.co.kr ,-,0
11811,-,개별종목,2024-12-31,한국투자증권(M&A/인수금융2부),재평가,마이다스제8호사모투자,1101130031798 ,B01,0,-,분기 ,2024-12-31,2025-01-03,2025-01-10,-,강성은, 1.0 ,강성은,강성은,강성은,202412,[Y]금융기관,"정민규대리, 유현희",02-3276-5826 ,mk.jeong@koreainvestment.com; hh.you@koreainvestment.com,회계반영,0
11812,-,기초자산,한국투자증권(M&A/인수금융2부)펀드(기초자산),마이다스제8호사모투자,재평가,미래아이엔씨,1101112068941 ,A07,0,-,분기 ,2024-12-31,2025-01-03,보고서제공X,-,강성은, 0.4 ,강성은,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,0
11813,-,기초자산,한국투자증권(M&A/인수금융2부)펀드(기초자산),마이다스제8호사모투자,재평가,"아이엠티씨(구,비긴바이오)",1801110875336 ,A07,0,-,분기 ,2024-12-31,2025-01-03,보고서제공X,-,강성은, 0.4 ,강성은,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,0
11814,-,개별종목,2024-12-31,미래에셋생명보험(LT),재평가,신한AIM크레딧일반사모투자신탁제3-A호,KBP2019090117,B02,0,-,미정,2024-12-31,룩스루,룩스루,-,대체평가3사업본부, - ,대체평가3사업본부,-,-,202412,[T]기타보험기관[1본부],강성준매니저,"02-3271-4759,010-2959-2125",kangsj713@miraeasset.com,-,0
11815,-,개별종목,2024-12-31,미래에셋생명보험(LT),재평가,신한AIM크레딧일반사모투자신탁제3-B호,KBP2019090118,B02,0,-,미정,2024-12-31,룩스루,룩스루,-,대체평가3사업본부, - ,대체평가3사업본부,-,-,202412,[T]기타보험기관[1본부],강성준매니저,"02-3271-4759,010-2959-2125",kangsj713@miraeasset.com,-,0
11816,-,기초자산,현대해상펀드(기초자산),KTBN16호벤처투자조합,재평가,"에피바이오텍(구,스템모어)",1201110795817 ,A07,1,-,분기 ,2024-12-31,2024-12-20,보고서제공X,-,서경덕, - ,서경덕,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,0
11817,-,기초자산,한국투자증권(기획조정실)펀드(기초자산),한국투자바이오글로벌펀드,신규,무모스튜디오,1101117056371 ,D06,0,-,분기,2024-12-31,2025-01-06,보고서제공X,-,원정우, - ,원정우,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,0
11818,-,기초자산,한국투자증권(기획조정실)펀드(기초자산),한국투자바이오글로벌펀드,신규,Pavilion Data Systems,KBP2021120203,A05,1,-,분기,2024-12-31,2025-01-06,보고서제공X,-,유재호, - ,유재호,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,0
11819,-,기초자산,한국투자증권(기획조정실)펀드(기초자산),한국투자바이오글로벌펀드,신규,Imel Biotherapeutics,KBP2021120228,D06,0,-,분기,2024-12-31,2025-01-06,보고서제공X,-,이문수, - ,오수현,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,2
11820,-,기초자산,한국투자증권(기획조정실)펀드(기초자산),한국투자바이오글로벌펀드,신규,Geneos Therapeutics,KBP2021120223,A05,1,-,분기,2024-12-31,2025-01-06,보고서제공X,-,원정우, - ,원정우,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,0
11821,-,기초자산,한국투자증권(기획조정실)펀드(기초자산),한국투자바이오글로벌펀드,신규,Eyevensys,KBP2021120226,A05,1,-,분기,2024-12-31,2025-01-06,보고서제공X,-,신원준, - ,신원준,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,0
11822,-,기초자산,한국투자증권(기획조정실)펀드(기초자산),한국투자바이오글로벌펀드,신규,메디히어,1101116722684 ,A07,0,-,분기,2024-12-31,2025-01-06,보고서제공X,-,이상민, - ,이상민,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,0
11823,-,기초자산,흥국생명보험(지분증권)펀드(기초자산),흥국하나에스앤비뉴프라임신기술투자조합,신규,크라이오에이치앤아이,1313110240758 ,A07,0,-,분기,2024-12-31,2024-12-12,보고서제공X,-,김미성, - ,신규,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,1
11824,-,기초자산,흥국생명보험(지분증권)펀드(기초자산),흥국하나에스앤비뉴프라임신기술투자조합,신규,씨케이이엠솔루션,1545110099063 ,A07,0,-,분기,2024-12-31,2024-12-12,보고서제공X,-,변혜진, - ,변혜진,-,-,202412,[6]기타기관펀드(기초자산),0,0,0,-,0
11825,평가최종값 : 2024-12-31,개별종목,2024-11-11,KTBN16호벤처투자조합,재평가,"에피바이오텍(구,스템모어)",1201110795817 ,A07,0,-,연말,2024-12-31,2024-12-16,2025-01-17,-,서경덕, - ,서경덕,유재호,유재호,202412,[D]KTB그룹,이현욱대리,"031-628-6420, 010-2765-9167",hwklee@daolinvestment.com,-,0
11826,-,개별종목,2024-12-26,에이아이에이생명보험(수익증권),신규,Ares Capital Europe VI ,KBP2024120249,B02,0,-,연말,2024-12-31,2025-01-17,2025-01-23,-,대체평가3사업본부, - ,대체평가3사업본부,-,-,202412,[T]기타보험기관[1본부],이성윤차장,02-3707-4894,sungyoon.lee@aia.com,회계반영,0
11827,TRS,개별종목,2024-12-31,이마트에브리데이,재평가,에브리데이리테일제일차,1101140132784 ,A00,0,-,분기 ,2024-12-31,2025-01-06,2025-01-07,-,김영규, 1.0 ,김영규,김영규,김영규,202412,[X]일반기업,김미란매니저,02-380-5940,043750@emarteveryday.co.kr;miran82@emart.com,-,0
11828,TRS,개별종목,2024-12-31,이마트에브리데이,재평가,에브리데이리테일제일차,1101140132784 ,D06,0,-,분기 ,2024-12-31,2025-01-06,2025-01-07,-,김영규, - ,김영규,김영규,김영규,202412,[X]일반기업,김미란매니저,02-380-5940,043750@emarteveryday.co.kr;miran82@emart.com,-,0
11829,TRS,개별종목,2024-12-31,이마트에브리데이,재평가,에브리데이리테일제이차,1101115817626 ,A00,0,-,분기 ,2024-12-31,2025-01-06,2025-01-07,-,김영규, 1.0 ,김영규,김영규,김영규,202412,[X]일반기업,김미란매니저,02-380-5940,043750@emarteveryday.co.kr;miran82@emart.com,-,0
11830,TRS,개별종목,2024-12-31,이마트에브리데이,재평가,에브리데이리테일제이차,1101115817626 ,D06,0,-,분기 ,2024-12-31,2025-01-06,2025-01-07,-,김영규, - ,김영규,김영규,김영규,202412,[X]일반기업,김미란매니저,02-380-5940,043750@emarteveryday.co.kr;miran82@emart.com,-,0
11831,TRS,개별종목,2024-12-31,케이비증권,재평가,에브리데이리테일제일차,1101140132784 ,D06,0,-,분기 ,2024-12-31,2025-01-06,2025-01-07,-,김영규, - ,김영규,김영규,김영규,202412,[Y]금융기관,최지식부장,02-6114-0871,choijisik@kbfg.com,-,0
11832,TRS,개별종목,2024-12-31,케이비증권,재평가,에브리데이리테일제이차,1101115817626 ,D06,0,-,분기 ,2024-12-31,2025-01-06,2025-01-07,-,김영규, - ,김영규,김영규,김영규,202412,[Y]금융기관,최지식부장,02-6114-0871,choijisik@kbfg.com,-,0
11833,-,개별종목,2024-12-31,"엔에스이엔엠(구,아이오케이컴퍼니)(상장)",재평가,"엔에스이엔엠(구,아이오케이컴퍼니)",1101111952567 ,D02,18,-,반기 ,2024-12-31,2025-01-17,2025-01-21,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202412,[W]상장기업,허준호과장,010-2287-7378,90hjhy87@iok.co.kr ,-,0
11834,-,개별종목,2024-12-31,"엔에스이엔엠(구,아이오케이컴퍼니)(상장)",재평가,제이준코스메틱,1341110001672 ,D02,31,-,반기 ,2024-10-08,2025-01-17,2025-01-21,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202412,[W]상장기업,허준호과장,010-2287-7378,90hjhy87@iok.co.kr ,-,0
11835,-,개별종목,2024-12-31,"엔에스이엔엠(구,아이오케이컴퍼니)(상장)",재평가,제이준코스메틱,1341110001672 ,D02,311,-,반기 ,2024-12-31,2025-01-17,2025-01-21,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202412,[W]상장기업,허준호과장,010-2287-7378,90hjhy87@iok.co.kr ,-,0
11836,-,개별종목,2024-12-31,키움증권,신규,파라다이스,1101110129274 ,D02,7,Y,분기 ,2024-12-31,2025-01-09,2025-01-10,2025-01-10,상장, - ,상장,심태진,심태진,202412,[Y]금융기관,재무팀이학인과장,02-3787-9741 ,hokijo@kiwoom.com; clark@kiwoom.com; jskim9900@kiwoom.com ,-,0
